| 摘要: |
| ［摘要］ 该文综述近年来非ST段抬高型急性冠状动脉综合征抗栓治疗的研究进展。抗栓药物包括抗血小板药和抗凝药，其中抗血小板药有阿司匹林、磷酸腺苷(ADP)受体拮抗剂和血小板膜糖蛋白(GPⅡb/Ⅲa)受体拮抗剂等；抗凝药有普通肝素和低分子肝素、抗Xa因子抑制药和直接凝血酶抑制剂等。 |
| 关键词: 非ST段抬高型急性冠状动脉综合征 不稳定型心绞痛 抗栓治疗 |
| DOI：10.3969/j.issn.1674-3806.2014.05.31 |
| 分类号:R 54 |
| 基金项目: |
|
| Antithrombotic treatment advance of non-ST-segment elevation acute coronary syndrome |
|
WEI Xiao, YIN Rui-xing
|
|
Department of Cardiology, the People′s Hospital of Luocheng Mulao Autonmous County, Guangxi 546400, China
|
| Abstract: |
| ［Abstract］ The antithrombotic treatment advance on non-ST-segment elevation acute coronary syndrome in recent several years was reviewed in this paper. There are two kinds of antithrombotic drugs, antiplatelet and anticoagulant drugs. The antiplatelet agents include aspirin, adenosine monophosphate(ADP) receptor antagonist and platelet membrane glycoprotein(GPⅡb/Ⅲa) antibody antagonist. The anticoagulant drugs consist of heparin, low molecular weight heparin, anti factor Xa inhibitors and the direct thrombin inhibitor etc. |
| Key words: Non-ST-segment elevation acute coronary syndromes Unstable angina pectoris Antithrombotic treatment |
